UK markets close in 7 hours 43 minutes

Nova Leap Health Corp. (NLH.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.2600+0.0100 (+4.00%)
At close: 03:31PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 22.41M
Enterprise value 23.82M
Trailing P/E N/A
Forward P/E 18.98
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.63
Price/book (mrq)0.88
Enterprise value/revenue 0.90
Enterprise value/EBITDA -139.31

Trading information

Stock price history

Beta (5Y monthly) 1.56
52-week change 333.33%
S&P500 52-week change 325.59%
52-week high 30.3000
52-week low 30.1250
50-day moving average 30.2423
200-day moving average 30.2166

Share statistics

Avg vol (3-month) 315.22k
Avg vol (10-day) 311.13k
Shares outstanding 586.21M
Implied shares outstanding 686.21M
Float 851.2M
% held by insiders 139.78%
% held by institutions 10.00%
Shares short (30 Apr 2024) 4221
Short ratio (30 Apr 2024) 40.02
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.00%
Shares short (prior month 28 Mar 2024) 42.06k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -4.03%
Operating margin (ttm)4.85%

Management effectiveness

Return on assets (ttm)1.28%
Return on equity (ttm)-5.72%

Income statement

Revenue (ttm)26.18M
Revenue per share (ttm)0.30
Quarterly revenue growth (yoy)-3.40%
Gross profit (ttm)N/A
EBITDA 994.47k
Net income avi to common (ttm)-1.05M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)894.76k
Total cash per share (mrq)0.01
Total debt (mrq)1.4M
Total debt/equity (mrq)7.68%
Current ratio (mrq)1.59
Book value per share (mrq)0.21

Cash flow statement

Operating cash flow (ttm)2.15M
Levered free cash flow (ttm)1.95M